✦ LIBER ✦

Phase II study of fludarabine phosphate for gastric adenocarcinoma

✍ Scribed by Lary J. Kilton; Julia B. Ashenhurst; James L. Wade; Richard L. Schilsky; Gail Shiomoto; Richard R. Blough; Suzanne L. French; Al. B. Benson

Publisher: Springer US
Year: 1994
Tongue: English
Weight: 234 KB
Volume: 12
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00874450

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of fludarabine phosphate

Phase II trial of fludarabine phosphate for adenocarcinoma of the pancreas

✍ Lary J. Kilton; Al B. Benson; Alice Greenberg; Patricia Johnson; Charles Shapiro 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 235 KB

Phase II study of amonafide in gastric a

Phase II study of amonafide in gastric adenocarcinoma

✍ Michael R. Mullane; Richard L. Schilsky; Rosemary B. Carroll; James L. Wade; Lar 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 285 KB

Phase II trial of piroxantrone in metast

Phase II trial of piroxantrone in metastatic gastric adenocarcinoma

✍ Richard Pazdur; Beth Bready; Anthony J. Scalzo; James E. Brandof; David R. Close 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 213 KB

Phase II evaluation of fludarabine phosp

Phase II evaluation of fludarabine phosphate in patients with central nervous system tumors

✍ Sarah A. Taylor; John Crowley; F. Stephen Vogel; Jeannette J. Townsend; Harmon J 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 147 KB

Twenty-three patients with malignant central nervous system tumors were treated with fludarabine phosphate (2-FAMP) on a 5 day bolus schedule. One brief partial response was observed in 20 malignant astrocytoma patients. 2FAMP as given in this protocol is inactive in previously treated patients with

Phase II trial of fludarabine phosphate

Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced breast cancer

✍ A. Mittelman; R. Ashikari; T. Ahmed; S. Savona; P. Arnold; Z. Arlin 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 181 KB

Eighteen patients with advanced breast cancer were entered into a phase II study of fludarabine phosphate. Fludarabine phosphate was given by continuous infusion for 5 days, at a starting dose of 20 mg/m2 per day for patients previously treated with two or more regimens and 25 mg/m2 per day for mini

Phase II study of amonafide in advanced

Phase II study of amonafide in advanced pancreatic adenocarcinoma

✍ Kaye Linke; Richard Pazdur; James L. Abbruzzese; Jaffer A. Ajani; Rodger Winn; J 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 262 KB

To determine the efficacy of amonafide in patients with advanced, measurable pancreatic adenocarcinoma, 15 patients previously untreated with chemotherapy were entered on a phase II trial. The starting dose was 400 mg/m 2 administered daily over 1 hr for 5 consecutive days repeated every 3 weeks. Be